About
Team
Publications
Webinars/Workshops
Projects
Posts
Public Resources
Gallery
Contact
S. M. O'Donovan
Latest
Assessing the effects of antipsychotic medications on schizophrenia functional analysis: a postmortem proteome study
Schizophrenia: a disorder of broken brain bioenergetics
The active kinome: The modern view of how active protein kinase networks fit in biological research
Editorial overview: Neuroscience: Advances in the field
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
Role of Astrocytes in Major Neuropsychiatric Disorders
KEOPS complex expression in the frontal cortex in major depression and schizophrenia
KEOPS complex expression in the frontal cortex in major depression and schizophrenia
Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach
Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter
Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia
A bioinformatic inquiry of the EAAT2 interactome in postmortem and neuropsychiatric datasets
Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia
Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia
Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments
Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia
Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia
Cell-subtype-specific changes in adenosine pathways in schizophrenia
Defects in Bioenergetic Coupling in Schizophrenia
The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders
Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression
Shaping plasticity: Alterations in glutamate transporter localization as a pathophysiological mechanism in severe mental illness
Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?
Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia
Cite
×